Official opening of Scottish Centre for Regenerative Medicine and bio-incubator facility, Nine, marks milestone in the growth of Edinburgh BioQuarter.
Research into conditions such as multiple sclerosis and heart and liver disease will benefit from multi-million stem cell research and life sciences facilities due to be opened today (Monday, 28th May) by HRH, the Princess Royal.
The Princess Royal unveiled plaques this afternoon at the £54 million Scottish Centre for Regenerative Medicine (SCRM) and £24 million bio-incubator facility, Nine, in Edinburgh.
The University of Edinburgh’s Scottish Centre for Regenerative Medicine will carry out cutting-edge stem cell research to help find therapies for
In a couple of months, the first test to verify if embryonic stem cells directly injected inside patients’ brain plagued by stroke can regenerate damaged areas, will start in Scotland.
A team from Southern General Hospital of Glasgow selected 4 groups of 3 patients that will be treated during the next 2 years.
Firstly patients will take a dose of 2 millions embryonic stem cells. The amount will be gradually increased to 20 millions of stem cells, which is what doctors think patients need to start the re-creating processes.
Image via Wikipedia
From stem cells comes a ray of light for those who lives in the dark. A new surgical operation anti-blindness is under examimation by a team of Scottish scientists from Edinburgh and Glasgow, ready to start a study about using adult stem cells on 20 patients suffering of cornea blindness: this disease plague over than 80% of the senior citizens.
“We can note 2 or 3 new cases of cornea blindness every month; it’s a big problem” says Bal Dhillow from Princess Alexandra Eye Pavillon of Edinburgh.
The experimental technique contemplate using of adult stem cells taken from a
Image by steve p2008 via Flickr
After making news on several occasions, scientists may have made a definitive breakthrough, with the first possible transfusion using blood obtained from embryonic stem cells possibly coming within the next three years. The transfusion would be done with type O blood, which can be donated to any patient, and would be obtained by researchers using excess embryos from assisted fertilization. The project, which will be led by Marc Turner of Edinburgh University, will also receive contributions from the Transfusion and Transplant Service of the British National Health Service, as well as the